Bill
Bill > S08925
NY S08925
NY S08925Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.
summary
Introduced
01/16/2026
01/16/2026
In Committee
01/16/2026
01/16/2026
Crossed Over
Passed
Dead
Introduced Session
2025-2026 General Assembly
Bill Summary
AN ACT to amend the general business law, in relation to prohibiting the sale of 7-hydroxymitragynine products
AI Summary
This bill prohibits the sale of products containing 7-hydroxymitragynine, a compound found in certain plants, if its concentration exceeds 2% of the total alkaloids or 1 milligram per serving. It defines "7-hydroxymitragynine products" broadly to include any substance, material, or finished goods containing this compound above the specified limits. The bill applies to all businesses operating in the state, including corporations, partnerships, limited liability companies, firms, and online platforms, making it illegal for them to knowingly sell, offer for sale, or deliver these prohibited products. Violators will face civil penalties: a maximum of $3,000 for a first offense and $6,500 for each subsequent offense, with these funds going to the New York state drug treatment and public education fund. The law will take effect 90 days after it becomes official.
Committee Categories
Business and Industry
Sponsors (2)
Last Action
REFERRED TO CONSUMER PROTECTION (on 01/16/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nysenate.gov/legislation/bills/2025/S8925 |
| BillText | https://assembly.state.ny.us/leg/?default_fld=&bn=S08925&term=2025&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#S08925 |
Loading...